Table 4.

Patients’ and physicians’ willingness to pay for diabetes treatment attributes

Attribute	Unit change	Patients			Physicians
		Monthly WTP (€)	95% CI		Monthly WTP (€)	95% CI
			Inferior (€)	Superior (€)		Inferior (€)	Superior (€)
Hypoglycemic events	Avoid one hypoglycemic event/month	54.80*	23.29	82.26	287.18	160.31	1,387.21
	Avoid one hypoglycemic event/week	51.59*	37.79	64.26	141.42	13.95	613.62
	Avoid one hypoglycemic event/year	3.87	0.34	24.81	114.18	35.29	409.49
Weight	Avoid gaining 3 kg/6 months	68.14	54.55	85.08	166.87	88.63	843.09
	Reduce 6 kg/6 months	25.75**	8.18	48.00	65.80	9.34	411.52
	Reduce 3 kg/6 months	44.07**	7.07	84.80	18.59	2.80	835.62
CVR	Decrease CVR	43.01	20.46	62.83	154.30	98.13	434.19
Nausea	Avoid nauseas	42.74	23.89	61.77	143.30	73.39	543.62
HbA1c	Avoid increasing HbA1c by 1%	24.28	18.41	30.31	125.92	73.30	622.75
Mode of administration	OAD instead of injections in relation to meals	30.16	25.33	34.86	69.07	44.99	100.39
	One injection less per day	25.65	17.09	35.91	26.66	11.79	45.89
	Administration irrespective of meals instead of in relation to meals	16.23	9.84	22.59	24.82	16.07	33.55
	OAD instead of injections irrespective of meals	13.93	7.63	20.55	1.84	0.27	22.25
Blood glucose monitoring	One blood glucose monitoring test less/day	10.19	7.18	13.91	39.55	27.61	56.18
	One blood glucose monitoring test less/month	0.34	0.24	0.46	1.32	0.92	1.87

Note:

^*Difference not statistically significant (P=0.8394).

^**Difference not statistically significant (P=0.3826).

Abbreviations: CI, confidence interval; CVR, cardiovascular risk; HbA_1c, glycated hemoglobin; OAD, oral antidiabetics; WTP, willingness to pay.